FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in New York, United States

Biotech startups that raised Series A in New York, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in New York, United States
One-time CSV
  • 81 funded companies, 66 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~new-york-united-states.csv81 rows × 18 columns
CompanyCityLast roundAmountDate
BiotiaLong Island CitySeries A$9.0M2026-10-01
Waypoint BioNew YorkSeries A$20.0M2026-05-27
Gilgamesh PharmaceuticalsNew YorkSeries A$60.0M2026-03-24
Neura HealthNew YorkSeries A$11.4M2025-09-29
Glyphic BiotechnologiesNew YorkSeries A$38.0M2025-09-26
Volastra TherapeuticsNew YorkSeries A$30.1M2025-09-23
LevelsNew YorkSeries A$10.0M2024-08-14
AuxiliusBrooklynSeries A$10.0M2024-03-15

8 rows of the CSV in 5 of its 18 columns.

81
Startups
$2.5B
Total raised
11
Funded in the last 12 months
$487.0M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

4 of 81
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Biotia Biotia is a health tech startup that offers AI solutions to diagnose and control infectious diseases. Artificial intelligence Long Island City Series A $9.0M 2026-10-01 $19.7M Everywhere Ventures, Sand Hill Angels, Tau Ventures +2 11 to 50 2016
Waypoint Bio Waypoint Bio applies spatial biology to improve cell therapy development. Artificial intelligence New York Series A $20.0M 2026-05-27 $34.5M Village Global, Fifty Years, Hummingbird Ventures +2 11 to 50 2021
Gilgamesh Pharmaceuticals Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company developing psychedelic drugs to treat mental illness. Biotech New York Series A $60.0M 2026-03-24 $142.6M Y Combinator, Alumni Ventures, Gaingels +2 11 to 50 2019
Auxilius Auxilius provides financial management software for clinical trials in biopharma. Biotech Brooklyn Series A $10.0M 2024-03-15 $20.0M Bain Capital Ventures, SignalFire, XYZ Venture Capital +1 11 to 50 2020

Table 1. Biotech startups that raised Series A in New York, United States: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 81.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Gilgamesh Pharmaceuticals Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company developing psychedelic drugs to treat mental illness. Biotech New York Series A $60.0M 2026-03-24 $142.6M Y Combinator, Alumni Ventures, Gaingels +2 11 to 50 2019
2 Waypoint Bio Waypoint Bio applies spatial biology to improve cell therapy development. Artificial intelligence New York Series A $20.0M 2026-05-27 $34.5M Village Global, Fifty Years, Hummingbird Ventures +2 11 to 50 2021
3 Biotia Biotia is a health tech startup that offers AI solutions to diagnose and control infectious diseases. Artificial intelligence Long Island City Series A $9.0M 2026-10-01 $19.7M Everywhere Ventures, Sand Hill Angels, Tau Ventures +2 11 to 50 2016

Table 2. Biotech startups that raised Series A in New York, United States: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Alumni Ventures Angel group Manchester, United States 3 4% 1 Gilgamesh Pharmaceuticals
2 Y Combinator Startup accelerator Mountain View, United States 2 2% 1 Gilgamesh Pharmaceuticals
3 National Institutes of Health Entrepreneurship program Bethesda, United States 2 2%
4 Catalio Capital Management Venture capital firm New York, United States 2 2%
5 Phoenix Venture Partners Venture capital firm San Mateo, United States 1 1% 1 Biotia
6 Everywhere Ventures Venture capital firm New York, United States 1 1% 1 Biotia
7 Tau Ventures Venture capital firm Palo Alto, United States 1 1% 1 Biotia
8 SeedToB Capital Venture capital firm Suwanee, United States 1 1% 1 Biotia
9 Sand Hill Angels Angel group Mountain View, United States 1 1% 1 Biotia
10 Hummingbird Ventures Venture capital firm Brussels, Belgium 1 1% 1 Waypoint Bio
11 Village Global Micro VC fund Covina, United States 1 1% 1 Waypoint Bio
12 MBX Capital Venture capital firm New York, United States 1 1% 1 Waypoint Bio
13 Fifty Years Micro VC fund San Francisco, United States 1 1% 1 Waypoint Bio
14 Boom Capital Ventures Venture capital firm San Francisco, United States 1 1% 1 Waypoint Bio
15 Prime Movers Lab Venture capital firm Jackson, United States 1 1% 1 Gilgamesh Pharmaceuticals

Table 3. Biotech startups that raised Series A in New York, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 71 88% $2.3B
Software 19 23% $469.3M
Artificial intelligence 15 19% $355.5M
Hardware 3 4% $87.0M
Cybersecurity 1 1% $18.0M

Table 4. Biotech startups that raised Series A in New York, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 81 100% $20.0M

Table 5. Biotech startups that raised Series A in New York, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
New York 66 81%
Brooklyn 5 6%
Rochester 2 2%
Long Island City 1 1%
Ithaca 1 1%
Great Neck 1 1%
Boston 1 1%
Troy 1 1%
Buffalo 1 1%
Melville 1 1%
Jericho 1 1%

Table 6. Biotech startups that raised Series A in New York, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 2 18% $13.0M
September 2026 1 9% $55.0M
June 2026 1 9% $20.0M
May 2026 2 18% $34.0M
April 2026 1 9% $47.0M
March 2026 2 18% $110.0M
January 2026 1 9% $138.0M
December 2025 1 9% $70.0M

Table 7. Biotech startups that raised Series A in New York, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 10 12% $417.0M
2025 11 14% $343.9M
2024 4 5% $130.0M
2023 8 10% $298.6M
2022 7 9% $67.8M
2021 14 17% $298.8M

Table 8. Biotech startups that raised Series A in New York, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 7 9%
2020 to 2022 18 22%
2015 to 2019 29 36%
2010 to 2014 18 22%
Before 2010 9 11%

Table 9. Biotech startups that raised Series A in New York, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 28 35%
11 to 50 45 57%
51 to 100 3 4%
101 to 250 2 3%
5,001 to 10,000 1 1%

Table 10. Biotech startups that raised Series A in New York, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in New York, United States whose last round is Series A are on the list?
81, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 81 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in New York, United States: 81 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in New York

Other sectors that raised Series A in New York

Cite: FundingWatcher, 81 biotech companies in New York, United States whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/new-york-united-states/